NeuroDerm Ltd. was a big mover last session, as the company saw its shares rise above 5% on the day. The move came on solid volume with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $16.67–$18.65 in the past one-month time frame.

In the last 30 days, the company has seen two upward estimate revisions and the Zacks Consensus Estimate also moved higher, suggesting that more solid trading could be ahead for NeuroDerm. So make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road.       

NeuroDerm currently carries a Zacks Rank #3 (Hold).

A better-ranked Medical-Drugs stock is Juniper Pharmaceuticals, Inc. , which sports a Zacks Rank #1 (Strong Buy).

Is NDRM going up? Or down? Predict to see what others think: Up or Down

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>